Resmed Inc. buy Needham & Company LLC
Start price
26.04.24
/
50%
€188.65
Target price
26.04.25
€220.14
Performance (%)
11.64%
End price
27.04.25
€210.60
Summary
This prediction ended on 27.04.25 with a price of €210.60. The prediction had a final performance of 11.64%. A total of €1.93 was paid as dividends for this prediction. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | 0.673% | 0.673% | -5.426% |
| iShares Core DAX® | 2,49 % | -5,94 % | 2,90 % |
| iShares Nasdaq 100 | 1,65 % | -2,46 % | 15,75 % |
| iShares Nikkei 225® | 0,55 % | -7,60 % | 30,35 % |
| iShares S&P 500 | 1,35 % | -2,94 % | 10,34 % |
Comments by Needham___Company_LL for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Needham & Company LLC from $224.00 to $236.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten